Home

Caterina Uberti Foppa

Location:

Department of Infectious Diseases

Languages:

Biography

Professor Caterina Uberti Foppa is an infectious disease specialist in the Infectious Diseases Unit at the IRCCS Ospedale San Raffaele Turro, led by Professor Antonella Castagna.

She also teaches at the Vita-Salute San Raffaele University in Milan, both in the Master's Degree Course in Medicine and Surgery and in the Infectious Diseases Specialization School. After earning her medical degree from the University of Milan in 1983, she specialized in Infectious and Tropical Diseases there in 1987.

Clinically, Professor Uberti Foppa focuses on infectious and tropical diseases, with particular attention to:

Hepatotropic viruses
Human Immunodeficiency Virus (HIV)
Coronaviruses

She also treats infections in immunocompromised patients.

She has authored and co-authored several scientific articles published in international journals and book chapters.

Do you need an appointment?

Request an appointment

Publications

Latest publications

Virological and Serological Discordant Profiles in COVID-19 Pneumonia: Two Atypical Clinical Cases.

Front Immunol. 2020 Oct 2;11:580867. doi: 10.3389/fimmu.2020.580867.

Ranzenigo M, Pastori C, Siracusano G, Pariani E, Uberti-Foppa C, Lopalco L.

Hepatocellular Carcinoma Screening Project Working Group for the Collaboration of Observational HIV on behalf of Epidemiological Research Europe (COHERE) In EuroCoord Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis

J Viral Hepat. 2019 Oct;26(10):1224-1228. doi: 10.1111/jvh.13146. Epub 2019 Jun 20.PMID: 31136059

Willemse S, Smit C, Sogni P, Sarcletti M, Uberti-Foppa C, Wittkop L, Raben D, D'Arminio Monforte A, Dabis F, Van Der Valk M;

COVID-BioB study group Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors

Clin Microbiol Infect. 2020 Oct 24:S1198-743X(20)30652-2. doi: 10.1016/j.cmi.2020.10.021. Online ahead of print.PMID: 33223114

Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, Muccini C, Monti G, De Luca G, Landoni G, Dagna L, Clementi M, Rovere Querini P, Ciceri F, Tresoldi M, Lazzarin A, Zangrillo A, Scarpellini P, Castagna A;

Pharmacotherapeutic management of HIV in transplant patients.

Expert Opin Pharmacother. 2019 Jul;20(10):1235-1250. doi: 10.1080/14656566.2019.1612364. Epub 2019 May 13.PMID: 31081726

Spagnuolo V, Uberti-Foppa C, Castagna A

Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?

Molecules. 2020 Dec 12;25(24):5888. doi:10.3390/molecules25245888.PMID: 33322757

Giovinazzo G, Gerardi C, Uberti-Foppa C, Lopalco L

Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort

Liver Int. 2020 Apr;40(4):769-777. doi: 10.1111/liv.14386. Epub 2020. Feb 3.PMID: 31970845

Soria A, Fava M, Bernasconi DP, Lapadula G, Colella E, Valsecchi MG, Migliorino GM, D'Ambrosio R, Landonio S, Schiavini M, Spinetti A, Carriero C, Degasperi E, Cologni G, Gatti F, Viganò P, Hasson H, Uberti-Foppa C, Pasulo L, Baiguera C, Rossotti R, Vinci M, Puoti M, Giorgini A, Menzaghi B, Lombardi A, Pan A, Aghemo A, Grossi PA, Boldizzoni R, Colombo S, Viganò M, Rumi MG, Del Poggio P, Valenti L, Giglio O, De Bona A, d'Arminio Monforte A, Colombo A, Spinelli O, Pigozzi MG, Molteni C, Bonfanti P, Terreni N, Perini P, Capretti A, Bella D, Liani C, Polo S, Aimo G, Pagnucco L, Bhoori S, Centenaro R, Graffeo M, Ciaccio A, Dionigi E, Lazzaroni S, Carderi I, Di Marco M, Rizzardini G, Noventa F, Lampertico P, Fagiuoli S.

Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients

PLoS One. 2017 Jul 31;12(7):e0181890. doi: 10.1371/journal.pone .0181890. eCollection 2017. PMID:28759568

Sagnelli C, Uberti-Foppa C, Hasson H, Bellini G, Minichini C, Salpietro S, Messina E, Barbanotti D, Merli M, Punzo F, Coppola N, Lazzarin A, Sagnelli E, Rossi F.:

Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis

Joint Bone Spine. 2017 May 18. pii: S1297-319X(17)30104-5. doi: 10.1016/j.jbspin.2017.05.013.

Sebastiani M, Atzeni F, Milazzo L, Quartuccio L, Scirè C, Gaeta GB, Lapadula G, Armignacco O, Tavio M, Olivieri I, Meroni P, Bazzichi L, Grassi W, Mathieu A, Mastroianni C, Sagnelli E, Santantonio T, Foppa CU, Puoti M, Sarmati L, Airò P, Epis OM, Scrivo R, Gargiulo M, Riva A, Manfredi A, Ciancio G, Zehender G, Taliani G, Meroni L, Sollima S, Sarzi-Puttini P, Galli M.

Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use

Drugs. 2017 May 12. doi: 10.1007/s40265-017-0753- PMID: 2849743.

Bagaglio S, Uberti-Foppa C, Morsica G.

NS3 protease resistance-associated substitutions in liver tissue and plasma samples from patients infected by hepatitis C virus genotype 1A or 1B

Arch Virol. 2017 Apr 18. doi: 10.1007/s00705-017-3341-1. PMID:2842136

Morsica G, Andolina A, Merli M, Messina E, Hasson H, Lazzarin A, Uberti-Foppa C, Bagaglio S.

Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals

J Hepatol. 2017 Apr 12. pii: S0168-8278(17)30203-9. doi:10.1016/j.jhep.2017.03.032 PMID: 28411040

Hasson H, Merli M, Messina E, Bhoori S, Salpietro S, Morsica G, Regalia E, Bagaglio S, Lazzarin A, Uberti-Foppa C, Mazzaferro V.

Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis

J Antimicrob Chemother. 2017 Mar 1;72(3):812-815. doi: 10.1093/jac/dkw492. PMID:2799901

Merli M, Galli L, Marinaro L, Ariaudo A, Messina E, Uberti-Foppa C, Castagna A, D'Avolio A, Lazzarin A, Bonora S, Hasson H.

TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype

World J Gastroenterol. 2016 Oct 14;22(38):8509-8518. PMID:2778496

Sagnelli C, Merli M, Uberti-Foppa C, Hasson H, Grandone A, Cirillo G, Salpietro S, Minichini C, Starace M, Messina E, Morelli P, Miraglia Del Giudice E, Lazzarin A, Coppola N, Sagnelli E

Frequency of Natural Resistance within NS5a Replication Complex Domain in Hepatitis C Genotypes 1a, 1b: Possible Implication of Subtype-Specific Resistance Selection in Multiple Direct Acting Antivirals Drugs Combination Treatment.Viruses

2016 Mar 25;8(4). pii: E91. doi: 10.3390/v8040091.PMID:27023593

Bagaglio S, Andolina A, Merli M, Uberti-Foppa C, Morsica G.

Reduced raltegravir clearance in HIV-infected liver transplant recipients: an unexpected interaction with immunosuppressive therapy?

Antimicrob Chemother. 2016 Jan 10. pii: dkv466. [Epub ahead of prin t] PMID: 26755497

Cattaneo D, Puoti M, Sollima S, Moioli C, Foppa CU, Baldelli S, Clementi E, Gervasoni C.J

Marked Decrease in Lymphocyte Count in HIV/Hepatitis C Virus (HCV)-Coinfected Patients With Advanced Liver Disease During Anti-HCV Treatment With Direct-Acting Antiviral Regimens Including Ribavirin

Clin Infect Dis. 2016 Feb 15;62(4):527-8. doi: 10 1093/cid/civ902 Epub 2015 Oct 27 PubMed PMID: 26508514

Merli M, Messina E, Salpietro S, Lazzarin A, Uberti-Foppa C, Hasson H.

Do you need an appointment?

Request an appointment